Stock Comparison
ARGX vs IONS
argenx NV ADR and Ionis Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$13.42B
P/E (TTM)
39.4
—
Forward P/E
34.0
90.9
Price/Sales
11.7
12.7
Price/Book
7.5
27.3
EV/EBITDA
33.9
135.8
Dividend Yield
—
—
Profitability
Net Margin
31.40%
-30.90%
Operating Margin
30.00%
-47.70%
Return on Equity
20.20%
-67.60%
Return on Assets
8.86%
-7.03%
Growth (YoY)
Revenue Growth
62.60%
87.00%
Earnings Growth
114.00%
-43.70%
Price & Risk
Beta
-0.0
0.4
52-Week High
$934.62
$86.74
52-Week Low
$510.06
$39.37
Analyst Target
$1,041.14
$105.91
Compare ARGX and IONS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.